{"cluster": 48, "subcluster": 92, "abstract_summ": "CONCLUSIONS: COVID\u201019 patients with comorbidities had worse clinical outcomes as compared to those without any comorbidity.Background: To investigate the risk factors related to aggravation and clinical outcomes in coronavirus disease 2019 (COVID-19) patients.We also found that novel risk factors, such as higher hypersensitive troponin I, predicted poor clinical outcomes.We also found novel risk factors, such as higher hypersensitive troponin I, predicted poor clinical outcomes.OBJECTIVES To identify the clinical characteristics and risk factors associated with the severe incidence of SARS-CoV-2 infection.", "title_summ": "Clinical Features and Predictors for Patients with Severe SARS-CoV-2 Pneumonia: a retrospective multicenter cohort studyInfluence factors of death risk among COVID-19 patients in Wuhan, China: a hospital-based case-cohort studyComorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide AnalysisRisk Factors Associated with Clinical Outcomes in 323 COVID-19 Patients in Wuhan, ChinaRisk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, ChinaRisk factors for disease progression in hospitalized patients with COVID-19: a retrospective cohort studyImpact of comorbidities on patients with COVID\u201019: A large retrospective study in Zhejiang, ChinaImpact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort studySars-CoV-2 infection in cancer patients undergoing active treatment.Analysis of clinical features and predictive factors for severe respiratory failure and deathRisk Factors Associated with Clinical Outcomes in 323 COVID-19 Hospitalized Patients in Wuhan, ChinaComorbidity and its impact on 1590 patients with Covid-19 in China: A Nationwide AnalysisRetrospective study of risk factors for severe SARS-Cov-2 infections in hospitalized adult patients.", "title_abstract_phrases": "CONCLUSIONS: COVID\u201019 patients with comorbidities had worse clinical outcomes as compared to those without any comorbidity.The numbers of lymphocytes and eosinophils were significantly lower in patients with critical disease than those with severe or moderate disease (p<0\u00b70001), and prothrombin time, D-dimer, and fibrin degradation products significantly increased with increasing disease severity (p<0\u00b70001).We compared patient characteristics and outcomes among patients with high, medium, and low admission viral loads and assessed whether viral load was independently associated with risk of intubation and in-hospital mortality.Here, we stratified COVID\u201019 patients based on their comorbidities to assess their risk of serious adverse outcomes.Of 200 COVID-19 patients, 163 (81.5%) had at least one of comorbidities, including diabetes, hypertension, hepatic disease, cardiac disease, chronic pulmonary disease and others."}